UK's Engitix, a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its propr...
Mitsui, the global network of healthcare organizations driving real-world research to accelerate the development of new ...
Japan-based National University Corporation Osaka University, Shimadzu Corporation, and SIGMAXYZ Inc. have signed an agr...
US' Ardelyx, has reached an agreement with its Japanese collaboration partner, Kyowa Kirin Co. Ltd., to amend the licens...
US-based Evozyne, Inc., an adaptive biology company pioneering evolution-based design of proteins, founded by Paragon Bi...
Japan's PENTAX Medical, a division of HOYA Group, has announced the appointment of Dr Klaus Mergener to the po...
AGC Inc., a Tokyo-based world-leading manufacturer of glass, chemicals, high-tech materials, has decided to expand ...
Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, and NEC Corporation in Japan have announced the ...
Japanese pharmaceutical company Shionogi & Co., Ltd., has selected Cloudera to boost its data analytics ca...
French firm Iktos, a company specialized in Artificial Intelligence (AI) for new drug design, and Japan's Teij...
US' Halozyme Therapeutics has announced a global collaboration and license agreement with Japan's Chugai Pharmaceutical ...
Otsuka Pharmaceutical has announced that its collaborator Akebia Therapeutics, Inc. (Akebia) has submitted a New Drug Ap...
PENTAX Medical, a division of HOYA Group, has announced the appointment of Rainer Burkard to the position of Global Pres...
Japan's Terumo Corporation and US-based Glooko have announced a technology integration to deliver new diabetes...
The Japanese Ministry of Health, Labor, and Welfare (MHLW) has granted marketing authorisation for Xenpozyme (olipu...
Daiichi Sankyo Company has obtained approval in Japan to change the indication of the analgesic 'Tarlige Tablets' (mirog...
Takeda has received approval from the Ministry of Health, Labour and Welfare (MHLW) for TAKHZYRO (lanadelumab) subc...
Health2Sync and Novo Nordisk Pharma Ltd. are partnering in Japan to support digital diabetes management and facilitate c...
